$27.54
0.010.04%
At close: Sep 20, 5:16 PM EDT
$27.55
0.010.04%
After Hours: Sep 20, 5:16 PM EDT
15 minutes delayed
Royalty Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Royalty Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $0.96 | $0.99 | -3.03 % |
Mar 2024 | 2024-05-09 | $0.98 | $0.99 | -1.01 % |
Dec 2023 | 2024-02-15 | $1.15 | $0.99 | 16.2 % |
Sep 2023 | 2023-11-08 | $0.79 | $0.77 | 2.60 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $537.00M | $628.26M | -14.5 % |
Mar 2024 | 2024-05-09 | $568.00M | $663.22M | -14.4 % |
Dec 2023 | 2024-02-15 | $596.00M | $673.65M | -11.5 % |
Sep 2023 | 2023-11-08 | $536.00M | $614.36M | -12.8 % |
Royalty Pharma (RPRX) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $0.96, which missed the estimate of $0.99.
The Actual Revenue was $537M, which missed the estimate of $628.3M.
Browse earnings estimates, EPS, and revenue on all stocks.